GlassScriptPhysician profile
Katherine Cregor
NPI 1861953630
$2,193.93
in general payments reported to CMS, 2019-2025
19 companies · $432 in 2025
The $432 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $376 · 2022: $659 · 2023: $378 · 2024: $348 · 2025: $432.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,042 · Education: $117.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,041.73 |
| Education | $116.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $821.45 | 2021-2024 | |
| Sun Pharmaceutical Industries INC. | $177.22 | 2022-2025 | |
| Amgen INC. | $145.70 | 2021-2025 | Otezla, Otezla |
| Genzyme Corporation | $144.98 | 2021-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $134.00 | 2022-2024 | Spevigo |
| Regeneron Healthcare Solutions, INC. | $133.78 | 2021-2025 | Libtayo, Dupixent |
| Lilly USA, LLC | $96.78 | 2021-2024 | Taltz, Olumiant, Ebglyss |
| Ucb, INC. | $83.89 | 2021-2025 | Bimzelx |
| E.R. Squibb & Sons, L.L.C. | $68.83 | 2022-2024 | Sotyktu |
| Leo Pharma INC. | $64.90 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $64.17 | 2022-2024 | |
| Genentech USA, INC. | $63.15 | 2022 | |
| Janssen Biotech, INC. | $50.63 | 2025 | Tremfya |
| Sandoz INC. | $47.35 | 2023-2025 | Hyrimoz |
| Incyte Corporation | $36.84 | 2022-2025 | Opzelura |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $24.76 | 2021 | |
| Springworks Therapeutics, INC. | $14.22 | 2025 | Gomekli |
| Helsinn Therapeutics (U.S.), INC. | $14.16 | 2023 | Valchlor |
| Biofrontera INC. | $7.12 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Katherine Cregor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.